Company Overview and News

5
Yuan's Fallout for Markets Means No Summer Break for Investors - Bloomberg

3h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
C.WSA C C.PRL C.PRJ C.PRK SCGLY C.PRG C.PRC C.WS.B SCGLF C.PRPCL CGBBW C.WS.A C.PRP C.PRU GLE C.PRS

5
MOVES-DWS adds executives to institutional client team

18h reuters
(Reuters) - Asset manager DWS Group GmbH & Co (DWSG.DE) said it made three senior appointments to its institutional client team across Europe.
AXAHF C.WSA C C.PRL C.PRJ CS C.PRK C.PRG AXJ C.PRC C.WS.B AXAHY BLK C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

8
Citigroup Hires From Rivals for Japan Prime Brokerage Expansion - Bloomberg

2018-07-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JPXGY MZHOF C.WSA DB OSCUF C C.PRL C.PRJ C.PRK C.PRG C.PRC FIG C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU 8697 8411 MFG C.PRS

5
AmEx rewards programme costs cloud strong quarterly results

2018-07-18 channelnewsasia
NEW YORK: American Express Co reported a steep rise in quarterly expenses as the credit card issuer spent more to fund its rewards programme, overshadowing its profit beat and sending its shares down 3.5 per cent in extended trading.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

5
AmEx rewards program costs cloud strong quarterly results

2018-07-18 reuters
(Reuters) - American Express Co (AXP.N) reported a steep rise in quarterly expenses as the credit card issuer spent more to fund its rewards program, overshadowing its profit beat and sending its shares down 3.5 percent in extended trading.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

5
AmEx rewards program costs cloud strong quarterly results

2018-07-18 channelnewsasia
American Express Co reported a 21 percent rise in quarterly profit on Wednesday as a strengthening U.S. economy drew in more customers and encouraged higher credit card spending.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

10
Wall Street traders set for best year since aftermath of crisis - Channel NewsAsia

2018-07-18 channelnewsasia
Wall Street trading desks may have reached a post-crisis turning point, with revenue on track for the best year since 2011, second-quarter earnings reports from big U.S. banks showed.
C.WSA GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS C.WS.B GLSSP C.WS.A C.PRP C.PRU MS C.PRS JBK C C.PRL GSC GS.PRICL C.PRJ TFG C.PRK C.PRG GSJ C.PRC GS.PRJ GS.PRI MS.PRI C.PRPCL GS.PRD MS.PRK CGBBW GS.PRC GJS GS.PRN GS.PRK

10
Wall Street traders set for best year since aftermath of crisis

2018-07-18 reuters
NEW YORK (Reuters) - Wall Street trading desks may have reached a post-crisis turning point, with revenue on track for the best year since 2011, second-quarter earnings reports from big U.S. banks showed.
C.WSA GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS C.WS.B GLSSP C.WS.A C.PRP C.PRU MS C.PRS JBK C C.PRL GSC GS.PRICL C.PRJ TFG C.PRK C.PRG GSJ C.PRC GS.PRJ GS.PRI MS.PRI C.PRPCL GS.PRD MS.PRK CGBBW GS.PRC GJS GS.PRN GS.PRK

5
Copper Prices Are About to Go on Steroids, Citi Says - Bloomberg

2018-07-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

14
14
North American Financial 15 Split Corp. Regular Monthly Dividend Declaration for Class A & Preferred Share

2018-07-18 globenewswire
TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- North American Financial 15 Split Corp. (The "Company") declares its regular monthly distribution of $0.10000 for each Class A share ($1.20 annually) and $0.04583 for each Preferred share ($0.550 annually). Distributions are payable August 10, 2018 to shareholders on record as at July 31, 2018.
MFC.PR.B C.WSA MFC.PR.F MFC.PR.C GS.PRB GS.PRA CIFAF GLSSP GWO JBK TFG GS.PRJ GS.PRI MFC 0945 GS.PRD CGBBW GS.PRC CIX SLFYF GS.PRN GWLIF SLF GS.PRK WFCNP FFN NAF.UN SLF WFC.PRL WFC.PRJ TD WFC.PRT GS C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP SLF.PR.G C.PRU WFC.PRY WFC.PRX TD SLF.PR.B WFC.PRW SLF.PR.E WFC.PRV C.PRS SLF.PR.D WFC WFC.WS TNTTF C.PRL C GSC GS.PRICL C.PRJ C.PRK C.PRG GSJ C.PRC SLF GWLOF C.PRPCL MFC.PR.I MFC.PR.J GWO.PR.I MFC GWO.PR.H MFC.PR.H GJS MFC.PR.M GWO.PR.F MFC.PR.N MFC.PR.K MFC.PR.L

14
Financial 15 Split Corp. Regular Monthly Dividend Declaration for Class A & Preferred Share

2018-07-18 globenewswire
TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. ("Financial 15") declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annually) and $0.04583 for each Preferred share ($0.550 annually). Distributions are payable August 10, 2018 to shareholders on record as at July 31, 2018.
MFC.PR.B C.WSA MFC.PR.F MFC.PR.C GS.PRB GS.PRA CIFAF GLSSP GWO JBK TFG GS.PRJ GS.PRI MFC 0945 GS.PRD CGBBW GS.PRC CIX SLFYF GS.PRN GWLIF SLF GS.PRK WFCNP SLF WFC.PRL WFC.PRJ TD WFC.PRT GS C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP SLF.PR.G C.PRU WFC.PRY WFC.PRX TD SLF.PR.B WFC.PRW SLF.PR.E WFC.PRV C.PRS SLF.PR.D WFC WFC.WS TNTTF C.PRL C GSC GS.PRICL C.PRJ C.PRK C.PRG GSJ C.PRC SLF GWLOF C.PRPCL MFC.PR.I MFC.PR.J GWO.PR.I MFC GWO.PR.H MFC.PR.H GJS MFC.PR.M GWO.PR.F MFC.PR.N MFC.PR.K MFC.PR.L

10
Oil's double slump shows market roiled by week of bearish news

2018-07-17 worldoil
Since the middle of last week, Brent crude had two of its largest single-day dollar declines in years. The cause of the rout: expanding supplies from nations where there had been major outages -- such as Libya -- at a time of mounting concerns about demand as a trade war between the U.S. and China escalates. As if that weren’t enough, signals from the physical cargo-trading market are suddenly looking weaker too.
C.WSA GS.PRB GS.PRA GS C.WS.B GLSSP C.WS.A C.PRP C.PRU C.PRS JBK C C.PRL GSC GS.PRICL C.PRJ TFG C.PRK C.PRG GSJ C.PRC GS.PRJ GS.PRI C.PRPCL GS.PRD CGBBW GS.PRC GJS GS.PRN GS.PRK

23
5 Strong Earnings Stocks to Buy Post-Netflix Plunge | InvestorPlace

2018-07-17 investorplace
Netflix, Inc. (NASDAQ:NFLX) may be plunging 14% right now. But don’t let that faze you. There is a reason why the Street has always been cautious about investing in Netflix. Even now I can see that top analysts only have a cautiously optimistic Buy rating on NFLX. And post-plunge they are still only modelling for 4% upside potential from current levels. Netflix is still expensive full stop.
WFCNP FB C.WSA WFC.PRL NFLX WFC.PRJ GOOG WFC.PRT C.WS.B ZION WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC VFC WFC.WS C C.PRL C.PRJ C.PRK NYTAB C.PRG C.PRC JPM GOOGL C.PRPCL CGBBW PNC RTN

10
Goldman Sachs beats on bond trading strength, names new CEO

2018-07-17 theedgemarkets
BENGALURU (July 17): Goldman Sachs Group Inc reported a better-than-expected quarterly profit on Tuesday and named bank insider David Solomon to replace long-time Chief Executive Lloyd Blankfein.
C.WSA GS.PRB GS.PRA GS C.WS.B GLSSP C.WS.A C.PRP C.PRU C.PRS JBK C C.PRL GSC GS.PRICL C.PRJ TFG C.PRK C.PRG GSJ C.PRC GS.PRJ GS.PRI C.PRPCL GS.PRD CGBBW GS.PRC GJS GS.PRN GS.PRK

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 172967572